Literature DB >> 28442565

Mind the magnesium, in dantrolene suppression of malignant hyperthermia.

Stephen C Cannon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28442565      PMCID： PMC5422787          DOI： 10.1073/pnas.1704103114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  21 in total

1.  Anaesthetic deaths in a family.

Authors:  M A DENBOROUGH; J F FORSTER; R R LOVELL; P A MAPLESTONE; J D VILLIERS
Journal:  Br J Anaesth       Date:  1962-06       Impact factor: 9.166

2.  Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.

Authors:  G G Harrison
Journal:  Br J Anaesth       Date:  1975-01       Impact factor: 9.166

Review 3.  Defective Mg2+ regulation of RyR1 as a causal factor in malignant hyperthermia.

Authors:  Derek S Steele; Adrian M Duke
Journal:  Arch Biochem Biophys       Date:  2006-03-20       Impact factor: 4.013

4.  Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.

Authors:  N Monnier; V Procaccio; P Stieglitz; J Lunardi
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

5.  Mechanism of control of skeletal-muscle contraction by dantrolene sodium.

Authors:  K O Ellis; J F Carpenter
Journal:  Arch Phys Med Rehabil       Date:  1974-08       Impact factor: 3.966

6.  Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium.

Authors:  K O Ellis; S H Bryant
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications.

Authors:  T E Nelson; M Lin; G Zapata-Sudo; R T Sudo
Journal:  Anesthesiology       Date:  1996-06       Impact factor: 7.892

8.  Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.

Authors:  D R Laver; V J Owen; P R Junankar; N L Taske; A F Dulhunty; G D Lamb
Journal:  Biophys J       Date:  1997-10       Impact factor: 4.033

9.  Myoplasmic free Mg2+ concentration during repetitive stimulation of single fibres from mouse skeletal muscle.

Authors:  H Westerblad; D G Allen
Journal:  J Physiol       Date:  1992       Impact factor: 5.182

10.  Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP.

Authors:  Paula L Diaz-Sylvester; Maura Porta; Julio A Copello
Journal:  Am J Physiol Cell Physiol       Date:  2008-02-27       Impact factor: 4.249
View more
  3 in total

Review 1.  Dantrolene : From Malignant Hyperthermia to Alzheimer's Disease.

Authors:  Yun Shi; Yong Wang; Huafeng Wei
Journal:  CNS Neurol Disord Drug Targets       Date:  2019       Impact factor: 4.388

2.  Junctional membrane Ca2+ dynamics in human muscle fibers are altered by malignant hyperthermia causative RyR mutation.

Authors:  Tanya R Cully; Rocky H Choi; Andrew R Bjorksten; D George Stephenson; Robyn M Murphy; Bradley S Launikonis
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-23       Impact factor: 11.205

Review 3.  Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches.

Authors:  Tokunbor A Lawal; Joshua J Todd; Katherine G Meilleur
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.